Abstract
Abstract
Background
The study aims to elicit a value set based on the EQ-VT for the EQ-5D-5L that can be used to support decision-making in Sweden.
Methods
Participants were recruited from the general population based on age, sex and urban/rural area quota sampling from five regions across Sweden. In total, 785 interviews were conducted from February 2020 to April 2021 using the EQVT 2.1 protocol, and both composite time trade-off (c-TTO) and discrete choice experiments (DCE) were used to elicit health preferences. A variety of models have been tested for the c-TTO data (generalized least square, Tobit, heteroskedastic models) and DCE data (conditional logit model), as well as the combined c-TTO and DCE data (hybrid modelling). Model selection was based on theoretical considerations, logical consistency of the parameter estimates, and significance of the parameters (p = 0.05). Model goodness-of-fit was assessed by AIC and BIC, and prediction accuracy was assessed in terms of mean absolute error. The predictions for the EQ-5D-5L health states between models were compared using scatterplots.
Results
The preferred model for generating the value set was the heteroskedastic model based on the c-TTO data, with the health utilities ranging from -0.31 for the worst (55,555) to 1 for the best (11111) EQ-5D-5L states.
Conclusion
This is the first c-TTO-based social value set for the EQ-5D-5L in Sweden. It can be used to support the health utility estimation in economic evaluations for reimbursement decision making in Sweden.
Funder
EuroQol Research Foundation
Stockholms Läns Landsting
Umea University
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,General Medicine
Reference54 articles.
1. Dolan P. Thinking about it: thoughts about health and valuing QALYs. Health Econ. 2011;20:1407–16.
2. the Dental and Pharmaceutical Benefits Agency (Tandvårds och läkemedelsförmånsverkets, TLV). General guidelines for economic evaluations from the pharmaceutical benefits board [Internet]. Stockhom; 2003 p. 3. Report No.: LFNAR 2003:2. Available from: https://www.tlv.se/download/18.2e53241415e842ce95514e9/1510316396792/Guidelines-for-economic-evaluations-LFNAR-2003-2.pdf
3. the Swedish dental and pharmaceutical benefits agency (Tandvårds och läkemedelsförmånsverkets, TLV. Ändring i Tandvårds- och läkemedelsförmånsverkets allmänna råd (TLVAR 2003:2) om ekonomiska utvärderingar (in Swedish). [Changes in the dental and pharmaceutical benefits Agency´s guidance for economic evaluations]. [Internet]. Stockholm; 2017. Available from: https://www.tlv.se/download/18.467926b615d084471ac3230c/1510316374332/TLVAR_2017_1.pdf
4. Ryen L, Svensson M. The willingness to pay for a quality adjusted life year: a review of the empirical literature. Health Econ. 2015;24:1289–301.
5. Simon HA. Theory of games and economic behavior. John Von Neumann , Oskar Morgenstern. Am J Sociol. The University of Chicago Press; 1945;50:558–60.